Haemonetics Corp. (MASS) Corporate Update
Market Performance
- Trading session: 22 October 2026, 06:20 PM Central Europe.
- Price movement: down 0.93 % during the 24‑hour period.
- Current price: USD 118.19.
- Shares outstanding: 45.5 million.
- Market capitalization: USD 5.4 billion.
- Volume: USD 98.8 million of shares traded.
- Year‑to‑date change: up 7.92 % since the end of September.
- 200‑day simple moving average: USD 77.32.
- 52‑week range: highest USD 123.77 (13 Oct 2026), lowest USD 48.98 (29 Oct 2025).
Recent Strategic Announcements
- Haemonetics has announced a planned transition of its U.S. plasma collection facilities to the NexSys platform, with completion targeted for the end of 2027.
- The company disclosed a collaboration with Alentis Therapeutics to develop a therapeutic candidate for rare kidney and liver diseases. The partnership includes an upfront payment and potential milestone payments under a global agreement.
- These moves indicate a dual focus on operational consolidation (plasma platform) and expansion of its specialty medicine pipeline.
Investor Outlook
- Market participants are monitoring how the NexSys transition and the new therapeutic partnership will influence future earnings and the company’s competitive positioning in plasma processing and specialty medicine.
Comparable Stock Performance (24 h)
| Stock | Change | Price | Market Cap | P/E |
|---|---|---|---|---|
| Onemain (OMF) | +1.45 % | USD 56.77 | USD 6.4 bn | 8.45 |
| Cava (CAVA) | –4.26 % | USD 54.19 | USD 6.4 bn | 124.06 |
| United Bankshares (UBSI) | +0.08 % | USD 47.96 | USD 6.4 bn | 12.86 |
| Duolingo (DUOL) | –1.62 % | USD 142.22 | USD 6.4 bn | 16.7 |
| Txnm Energy (TXNM) | 0 % | USD 58.64 | USD 6.4 bn | 33.16 |
Company Profile Haemonetics Corporation, headquartered in Boston, United States, operates in the Health Care sector. The company designs, manufactures, and markets automated blood processing systems used for surgical blood salvage, blood component collections, and plasma collections. Its products are sold globally. Haemonetics is listed on the New York Stock Exchange and conducted its initial public offering on 9 May 1991. Further information can be found on the company’s website at www.haemonetics.com .
